Candel Therapeutics, Inc. (Duplicate)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Candel Therapeutics, Inc. (Duplicate)
IPO Edition: Caribou, AbSci and HCW launched initial public offerings, but three firms that were expected to go public during the week of 19-23 July did not, raising the question of whether investors are beginning to pull back from biopharma offerings.
Public Company Edition: Three $100m-plus US initial public offerings launched on 15 July after two smaller biopharma IPOs earlier in the month. Also, Gelesis announced a SPAC merger, Brii and Amniotics launched ex-US IPOs, and Intellia, Cerevel and Kymera priced large follow-on offerings.
- Gene Therapy, Cell Therapy